戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 pression of VEGFA and were protected against pathological neovascularization.
2 quired for normal vessel development and for pathological neovascularization.
3 he retina, suggesting that PGC-1alpha drives pathological neovascularization.
4 uld emerge as a good target for treatment of pathological neovascularization.
5 a useful therapeutic approach in diseases of pathological neovascularization.
6  already-established target for treatment of pathological neovascularization.
7 ed vascular loss followed by hypoxia-induced pathological neovascularization.
8  not protect the retina, but rather enhanced pathological neovascularization.
9 of many devastating diseases with associated pathological neovascularization.
10 st retinal vessels while suppressing ectopic pathological neovascularization.
11 terized by invasive synovial hyperplasia and pathological neovascularization.
12  have been shown to contribute to normal and pathological neovascularization.
13 etinal ischemia can cause vision-threatening pathological neovascularization.
14 novel target for the design of inhibitors of pathological neovascularization.
15 odronate-liposomes led to the suppression of pathological neovascularization.
16 ponses with an anti-CD2 antibody exacerbated pathological neovascularization.
17 omotes alternative macrophage activation and pathological neovascularization.
18 in RNA targeting Sema3e promoted disoriented pathological neovascularization and partially abolished
19 chemical inhibitor substantially reduced the pathological neovascularization and rescued visual funct
20 morphonuclear leukocytes (PMN) infiltration, pathological neovascularization, and up-regulation of me
21 t paper, the mechanisms of physiological and pathological neovascularization are compared and contras
22 ctors (VEGFs) are mainly responsible for the pathological neovascularization as in the case in neovas
23                                       During pathological neovascularization, both the absolute and r
24 expression of ADAM9 could potentially affect pathological neovascularization by increasing the sheddi
25 e findings may lead to methods of regulating pathological neovascularization by specifically targetin
26 eutic use, especially in retinopathies where pathological neovascularization compromises vision and l
27 fining the molecular pathways distinguishing pathological neovascularization from normal vessels is c
28 he role of this endogenous LXA(4) circuit in pathological neovascularization has not been determined.
29  and activity are significantly increased in pathological neovascularization in a mouse model of oxyg
30 r regrowth after injury, and hypoxia-induced pathological neovascularization in a mouse model of oxyg
31   TNF-alpha blockade diminished the enhanced pathological neovascularization in APN-KO mice by 34%, a
32                                              Pathological neovascularization in both the OIR and CNV
33 anscriptional regulatory roles in regulating pathological neovascularization in eye diseases.
34  recovery within ischemic tissue and reduces pathological neovascularization in OIR.
35 c MPs were selectively recruited to sites of pathological neovascularization in response to locally p
36 elial growth factor (VEGF) treatments reduce pathological neovascularization in the eye and in tumors
37 rotoxic anti-VEGF agents in the treatment of pathological neovascularization in the eye.
38 demonstrate that TIMP3 and erlotinib inhibit pathological neovascularization in the mouse retina, mos
39 decreases key glycolytic enzymes and reduces pathological neovascularization in the OIR mice.
40                    The mechanisms underlying pathological neovascularization in the retina remain inc
41  the first evidence for a role for ADAM17 in pathological neovascularization in vivo.
42                                              Pathological neovascularization is a critical component
43                                              Pathological neovascularization is a crucial component o
44 ch3 is induced in hypoxia and interestingly, pathological neovascularization is decreased in retinas
45 e immature retinal vasculature, resulting in pathological neovascularization (NV).
46                                       During pathological neovascularization, VEGF164 selectively ind
47 tently suppressed the leukocyte adhesion and pathological neovascularization, whereas it had little o
48 us contribute to postnatal physiological and pathological neovascularization, which is consistent wit
49            Further, Cyp27a1-null mice showed pathological neovascularization, which likely arose from
50 hibitors as therapeutic agents in inhibiting pathological neovascularization with a range of clinical
51 inhibitors of angiogenesis are able to block pathological neovascularization without harming the pree

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。